Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use VOXZOGO safely and effectively. See full prescribing information for VOXZOGO. VOXZOGO (vosoritide) for injection, for subcutaneous use Initial U.S. Approval: 2021
Medication labelWhy this: Advisory · dailymed-prescription
VOXZOGO is indicated to increase linear growth in pediatric patients with achondroplasia with open epiphyses. This indication is approved under accelerated approval based on an improvement in annualized growth velocity [see Clinical Studies (14)]. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trial(s).
- generic_name
- vosoritide
- brand_name
- water
- product_names
- vosoritide, water
- ndc
- 68135-082, 68135-082-36, 68135-061, 68135-061-00, 68135-070, 68135-070-12, 68135-119, 68135-119-66, 68135-094, 68135-094-84, 68135-102, 68135-102-43, 68135-181, 68135-181-93, 68135-130, 68135-130-92, 68135-158, 68135-158-17
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en